SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone

J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e86-e88. doi: 10.1111/jdv.17721. Epub 2021 Oct 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Biological Therapy
  • COVID-19*
  • Humans
  • Psoriasis* / drug therapy
  • SARS-CoV-2
  • Severity of Illness Index
  • Thalidomide / analogs & derivatives

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Thalidomide
  • apremilast